重组SARS-CoV-2 (2019-nCoV) Spike RBD-His蛋白

1, Wang, Y; et al. SARS‐CoV‐2 S1 is superior to the RBD as a COVID‐19 subunit vaccine antigen. Journal of medical virology, PMID: 32691875
2, Liu, T; et al. Quantification of antibody avidities and accurate detection of SARS-CoV-2 antibodies in serum and saliva on plasmonic substrates. Nature biomedical engineering, PMID: 33122853
3, Mazzini, L; et al. Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples. Journal of immunological methods, PMID: 33253698
4, Asandei, A; et al. Non-Receptor-Mediated Lipid Membrane Permeabilization by the SARS-CoV-2 Spike Protein S1 Subunit. ACS applied materials & interfaces, PMID: 33270413
5, Pradenas, E; et al. Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodes. Med (New York, N.Y.), PMID: 33554155
6, Golden, JW; et al. Human convalescent plasma protects K18-hACE2 mice against severe respiratory disease. The Journal of general virology, PMID: 33961540
7, Guo, K; et al. Rapid single-molecule detection of COVID-19 and MERS antigens via nanobody-functionalized organic electrochemical transistors. Nature biomedical engineering, PMID: 34031558
8, Schasfoort, RBM; et al. High throughput surface plasmon resonance imaging method for clinical detection of presence and strength of binding of IgM, IgG and IgA antibodies against SARS-CoV-2 during CoViD-19 infection. MethodsX, PMID: 34221910
9, Tang, J; et al. Epitope diversity of SARS-CoV-2 hyperimmune intravenous human immunoglobulins and neutralization of variants of concern. iScience, PMID: 34430803
10, Wu, K; et al. One-Step, Wash-free, Nanoparticle Clustering-Based Magnetic Particle Spectroscopy Bioassay Method for Detection of SARS-CoV-2 Spike and Nucleocapsid Proteins in the Liquid Phase. ACS applied materials & interfaces, PMID: 34499464
11, Maghsood, F; et al. Differential Antibody Response to SARS-CoV-2 Antigens in Recovered and Deceased Iranian COVID-19 Patients. Viral immunology, PMID: 34534012 1
2, Egorov, AI; et al. A Multiplex Noninvasive Salivary Antibody Assay for SARS-CoV-2 Infection and Its Application in a Population-Based Survey by Mail. Microbiology spectrum, PMID: 34523986 1
3, Wouters, E; et al. A novel competition ELISA for the rapid quantification of SARS-CoV-2 neutralizing antibodies in convalescent plasma. Transfusion, PMID: 34498761 1
4, Tang, J; et al. Antibody affinity maturation and cross-variant activity following SARS-CoV-2 mRNA vaccination: Impact of prior exposure and sex. EBioMedicine, PMID: 34902788 1
5, Qu, JH; et al. Innovative FO-SPR Label-free Strategy for Detecting Anti-RBD Antibodies in COVID-19 Patient Serum and Whole Blood. ACS sensors, PMID: 35061357 1
6, Dutt, TS; et al. Comprehensive Immune Profiling Reveals CD56+ Monocytes and CD31+ Endothelial Cells Are Increased in Severe COVID-19 Disease. Journal of immunology (Baltimore, Md. : 1950), PMID: 34987111 1
7, Fu, Y; et al. Interfering effects on the bioactivities of several key proteins of COVID-19/variants in diabetes by compounds from Lianqiao leaves: In silico and in vitro analyses. International journal of biological macromolecules, PMID: 35346677 1
8, Lee, Y; et al. SARS-CoV-2 mRNA vaccine induced higher antibody affinity and IgG titers against variants of concern in post-partum vs non-post-partum women. EBioMedicine, PMID: 35301181 1
9, Wussow, F; et al. COH04S1 and Beta Sequence Modified Vaccine Protect Hamsters From SARS-CoV-2 Variants. iScience, PMID: 35634578
20, Bixler, SL; et al. Exposure Route Influences Disease Severity in the COVID-19 Cynomolgus Macaque Model. Viruses, PMID: 35632755
21, Zimmerman, O; et al. mRNA vaccine boosting enhances antibody responses against SARS-CoV-2 Omicron variant in individuals with antibody deficiency syndromes. Cell Reports Medicine, PMID: 35688161 2
2, Emmenegger, M; et al. Both COVID-19 infection and vaccination induce high-affinity cross-clade responses to SARS-CoV-2 variants. iScience, PMID: 35875683 2
3, Wu, F; et al. Single-shot AAV-vectored vaccine against SARS-CoV-2 with fast and long-lasting immunity. Acta pharmaceutica Sinica. B, PMID: 35846427 2
4, Chiuppesi, F; et al. Vaccine-induced spike- and nucleocapsid-specific cellular responses maintain potent cross-reactivity to SARS-CoV-2 Delta and Omicron variants. iScience, PMID: 35846380 2
5, Besselink, G; et al. Asymmetric Mach-Zehnder Interferometric Biosensing for Quantitative and Sensitive Multiplex Detection of Anti-SARS-CoV-2 Antibodies in Human Plasma. Biosensors, PMID: 35892450 2
6, Koklu, A; et al. Convection Driven Ultrarapid Protein Detection via Nanobody-Functionalized Organic Electrochemical Transistors. Advanced materials (Deerfield Beach, Fla.), PMID: 35772173 2
7, Hawman, DW; et al. Replicating RNA platform enables rapid response to the SARS-CoV-2 Omicron variant and elicits enhanced protection in naïve hamsters compared to ancestral vaccine. EBioMedicine, PMID: 35932641 2
8, Lu, JG; et al. Structures, biomimetic synthesis, and anti-SARS-CoV-2 activity of two pairs of enantiomeric phenylpropanoid-conjugated protoberberine alkaloids from the rhizomes of Corydalis decumbens. Archives of pharmacal research, PMID: 36121609 2
9, Wu, J; et al. CD147 contributes to SARS-CoV-2-induced pulmonary fibrosis. Signal transduction and targeted therapy, PMID: 36424379
30, Wu, K; et al. Five-Minute Magnetic Nanoparticle Spectroscopy-Based Bioassay for Ultrafast Detection of SARS-CoV-2 Spike Protein. ACS applied nano materials, PMID: 36570474
31, Langel, SN; et al. Dam-Infant Rhesus Macaque Pairs to Dissect Age-Dependent Responses to SARS-CoV-2 Infection. ImmunoHorizons, PMID: 36547390 3
2, Emmenegger, M; et al. Protocol to determine antibody affinity and concentration in complex solutions using microfluidic antibody affinity profiling. STAR protocols, PMID: 36853663 3
3, Park, KS; et al. Ultra-sensitive label-free SERS biosensor with high-throughput screened DNA aptamer for universal detection of SARS-CoV-2 variants from clinical samples. Biosensors & bioelectronics, PMID: 36940632 3
4, Adams, LE; et al. Fc-mediated pan-sarbecovirus protection after alphavirus vector vaccination. Cell reports, PMID: 37000623 3
5, Tai, W; et al. An mRNA-based T-cell-inducing antigen strengthens COVID-19 vaccine against SARS-CoV-2 variants. Nature communications, PMID: 37221158 3
6, Wouters, E; et al. Intranasal administration of convalescent plasma protects against SARS-CoV-2 infection in hamsters. EBioMedicine, PMID: 37148586 3
7, Han, X; et al. Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines. Nature nanotechnology, PMID: 37365276 3
8, Chen, X; et al. PD-1/PD-L1 blockade restores tumor-induced COVID-19 vaccine bluntness. Vaccine, PMID: 37400286 3
9, Tong, X; et al. Waning and boosting of antibody Fc-effector functions upon SARS-CoV-2 vaccination. Nature communications, PMID: 37443074
40, Mulgaonkar, N; et al. Montelukast and Telmisartan as Inhibitors of SARS-CoV-2 Omicron Variant. Pharmaceutics, PMID: 37514075
41, Ou, BS; et al. Saponin Nanoparticle Adjuvants Incorporating Toll-Like Receptor Agonists Improve Vaccine Immunomodulation. bioRxiv : the preprint server for biology, PMID: 37577608 4
2, Chiuppesi, F; et al. Stimulation of Potent Humoral and Cellular Immunity via Synthetic Dual-Antigen MVA-Based COVID-19 Vaccine COH04S1 in Cancer Patients Post Hematopoietic Cell Transplantation and Cellular Therapy. Vaccines, PMID: 37766168 4
3, Stewart-Jones, GBE; et al. Domain-based mRNA vaccines encoding spike protein N-terminal and receptor binding domains confer protection against SARS-CoV-2. Science translational medicine, PMID: 37703353 4
4, Guo, Y; et al. The cryo-EM structure of homotetrameric attachment glycoprotein from langya henipavirus. Nature communications, PMID: 38280880 4
5, Khan, I; et al. Tubeimosides are pan-coronavirus and filovirus inhibitors that can block their fusion protein binding to Niemann-Pick C1. Nature communications, PMID: 38167417 4
6, Poulakou, G; et al. Anti-SARS-CoV-2 glyco-humanized polyclonal antibody XAV-19: phase II/III randomized placebo-controlled trial shows acceleration to recovery for mild to moderate patients with COVID-19. Frontiers in immunology, PMID: 38694503 4
7, Kinoshita, M; et al. Immunological Response to Subcutaneous and Intranasal Administration of SARS-CoV-2 Spike Protein in Mice. Vaccines, PMID: 38675726 4
8, Maji, D; et al. Enhancing In Vivo Electroporation Efficiency through Hyaluronidase: Insights into Plasmid Distribution and Optimization Strategies. Pharmaceutics, PMID: 38675208 4
9, Park, S; et al. An ancestral SARS-CoV-2 vaccine induces anti-Omicron variants antibodies by hypermutation. Nature communications, PMID: 38643233 50, Jansen, EB; et al. PASC (Post Acute Sequelae of COVID-19) is associated with decreased neutralizing antibody titers in both biological sexes and increased ANG-2 and GM-CSF in females. Scientific reports, PMID: 38684819 51, Ou, BS; et al. Saponin nanoparticle adjuvants incorporating Toll-like receptor agonists drive distinct immune signatures and potent vaccine responses. Science advances, PMID: 39110802 5
2, Verbrugghe, C; et al. Biochemical rationale for transfusion of high titre COVID-19 convalescent plasma. Scientific reports, PMID: 39384892 5
3, Esen, M; et al. First-in-Human Phase I Trial to Assess the Safety and Immunogenicity of an Orf Virus-Based COVID-19 Vaccine Booster. Vaccines, PMID: 39591190 5
4, Liu, Y; et al. Oral DNA Vaccine Utilizing the Yeast Cell Wall for Dectin-1 Receptor-Mediated Enhancement of Mucosal Immunity. Molecular pharmaceutics, PMID: 39960883 5
5, He, P; et al. Microneedle-delivered adeno-associated virus vaccine amplified anti-viral immunity by improving antigen-presenting cells infection. Journal of controlled release : official journal of the Controlled Release Society, PMID: 39875077 5
6, Verbrugghe, C; et al. Functional humoral response during intranasal convalescent plasma prophylaxis for SARS-CoV-2. The Journal of infectious diseases, PMID: 40408511 5
7, Bean, DJ; et al. Endemic coronavirus infection is associated with SARS-CoV-2 Fc receptor-binding antibodies. Journal of virology, PMID: 40387363 5
8, Wang, Y; et al. Engineered Dual-Function Antibody-Like Proteins to Combat SARS-CoV-2-Induced Immune Dysregulation and Inflammation. Advanced science (Weinheim, Baden-Wurttemberg, Germany), PMID: 40619617 5
9, Kishore, U; et al. Differential modulation of SARS-CoV-2 infection by complement factor H and properdin. Frontiers in immunology, PMID: 40895576 60, Tang, J; et al. Mechanisms of superior respiratory IgA responses against SARS-CoV-2 after mucosal vaccination. bioRxiv : the preprint server for biology, PMID: 41040255 61, Tebas, P; et al. Safety and pharmacokinetics of SARS-CoV-2 DNA-encoded monoclonal antibodies in healthy adults: a phase 1 trial. Nature medicine, PMID: 41120767